Literature DB >> 19029900

Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities.

Nicola Brunetti-Pierri1, Jonathan S Berg, Fernando Scaglia, John Belmont, Carlos A Bacino, Trilochan Sahoo, Seema R Lalani, Brett Graham, Brendan Lee, Marwan Shinawi, Joseph Shen, Sung-Hae L Kang, Amber Pursley, Timothy Lotze, Gail Kennedy, Susan Lansky-Shafer, Christine Weaver, Elizabeth R Roeder, Theresa A Grebe, Georgianne L Arnold, Terry Hutchison, Tyler Reimschisel, Stephen Amato, Michael T Geragthy, Jeffrey W Innis, Ewa Obersztyn, Beata Nowakowska, Sally S Rosengren, Patricia I Bader, Dorothy K Grange, Sayed Naqvi, Adolfo D Garnica, Saunder M Bernes, Chin-To Fong, Anne Summers, W David Walters, James R Lupski, Pawel Stankiewicz, Sau Wai Cheung, Ankita Patel.   

Abstract

Chromosome region 1q21.1 contains extensive and complex low-copy repeats, and copy number variants (CNVs) in this region have recently been reported in association with congenital heart defects, developmental delay, schizophrenia and related psychoses. We describe 21 probands with the 1q21.1 microdeletion and 15 probands with the 1q21.1 microduplication. These CNVs were inherited in most of the cases in which parental studies were available. Consistent and statistically significant features of microcephaly and macrocephaly were found in individuals with microdeletion and microduplication, respectively. Notably, a paralog of the HYDIN gene located on 16q22.2 and implicated in autosomal recessive hydrocephalus was inserted into the 1q21.1 region during the evolution of Homo sapiens; we found this locus to be deleted or duplicated in the individuals we studied, making it a probable candidate for the head size abnormalities observed. We propose that recurrent reciprocal microdeletions and microduplications within 1q21.1 represent previously unknown genomic disorders characterized by abnormal head size along with a spectrum of developmental delay, neuropsychiatric abnormalities, dysmorphic features and congenital anomalies. These phenotypes are subject to incomplete penetrance and variable expressivity.

Entities:  

Mesh:

Year:  2008        PMID: 19029900      PMCID: PMC2680128          DOI: 10.1038/ng.279

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  25 in total

1.  ABase-a tool for the rapid assessment of anthropometric measurements on handheld computers.

Authors:  Andreas Zankl; Luciano Molinari
Journal:  Am J Med Genet A       Date:  2003-08-30       Impact factor: 2.802

2.  Regional assignment of the human loci for uvomorulin (UVO) and chymotrypsinogen B (CTRB) with the help of two overlapping deletions on the long arm of chromosome 16.

Authors:  E Natt; R E Magenis; J Zimmer; A Mansouri; G Scherer
Journal:  Cytogenet Cell Genet       Date:  1989

3.  Congenital hydrocephalus in hy3 mice is caused by a frameshift mutation in Hydin, a large novel gene.

Authors:  Brian E Davy; Michael L Robinson
Journal:  Hum Mol Genet       Date:  2003-05-15       Impact factor: 6.150

4.  Interstitial deletion of chromosome 16q: 16q22 is critical for 16q- syndrome.

Authors:  M Fujiwara; T Yoshimoto; Y Morita; M Kamada
Journal:  Am J Med Genet       Date:  1992-06-01

5.  Head circumference in 'preschizophrenic' and control neonates.

Authors:  T F McNeil; E Cantor-Graae; L G Nordström; T Rosenlund
Journal:  Br J Psychiatry       Date:  1993-04       Impact factor: 9.319

6.  Deletions within chromosome 22q11 in familial congenital heart disease.

Authors:  D I Wilson; J A Goodship; J Burn; I E Cross; P J Scambler
Journal:  Lancet       Date:  1992-09-05       Impact factor: 79.321

7.  Chromosome 1q21.1 contiguous gene deletion is associated with congenital heart disease.

Authors:  Jesse Christiansen; John D Dyck; Basil G Elyas; Margaret Lilley; J Stephen Bamforth; Mark Hicks; Kathleen A Sprysak; Robert Tomaszewski; Shelagh M Haase; Leanne M Vicen-Wyhony; Martin J Somerville
Journal:  Circ Res       Date:  2004-04-29       Impact factor: 17.367

8.  High resolution mapping of interstitial long arm deletions of chromosome 16: relationship to phenotype.

Authors:  D F Callen; H Eyre; S Lane; Y Shen; I Hansmann; N Spinner; E Zackai; D McDonald-McGinn; S Schuffenhauer; J Wauters
Journal:  J Med Genet       Date:  1993-10       Impact factor: 6.318

9.  Protein-truncating mutations in ASPM cause variable reduction in brain size.

Authors:  Jacquelyn Bond; Sheila Scott; Daniel J Hampshire; Kelly Springell; Peter Corry; Marc J Abramowicz; Ganesh H Mochida; Raoul C M Hennekam; Eamonn R Maher; Jean-Pierre Fryns; Abdulrahman Alswaid; Hussain Jafri; Yasmin Rashid; Ammar Mubaidin; Christopher A Walsh; Emma Roberts; C Geoffrey Woods
Journal:  Am J Hum Genet       Date:  2003-10-21       Impact factor: 11.025

10.  ASPM is a major determinant of cerebral cortical size.

Authors:  Jacquelyn Bond; Emma Roberts; Ganesh H Mochida; Daniel J Hampshire; Sheila Scott; Jonathan M Askham; Kelly Springell; Meera Mahadevan; Yanick J Crow; Alexander F Markham; Christopher A Walsh; C Geoffrey Woods
Journal:  Nat Genet       Date:  2002-09-23       Impact factor: 38.330

View more
  241 in total

1.  Rare copy number variants in tourette syndrome disrupt genes in histaminergic pathways and overlap with autism.

Authors:  Thomas V Fernandez; Stephan J Sanders; Ilana R Yurkiewicz; A Gulhan Ercan-Sencicek; Young-Shin Kim; Daniel O Fishman; Melanie J Raubeson; Youeun Song; Katsuhito Yasuno; Winson S C Ho; Kaya Bilguvar; Joseph Glessner; Su Hee Chu; James F Leckman; Robert A King; Donald L Gilbert; Gary A Heiman; Jay A Tischfield; Pieter J Hoekstra; Bernie Devlin; Hakon Hakonarson; Shrikant M Mane; Murat Günel; Matthew W State
Journal:  Biol Psychiatry       Date:  2011-12-14       Impact factor: 13.382

Review 2.  The genetics of Tourette disorder.

Authors:  Matthew W State
Journal:  Curr Opin Genet Dev       Date:  2011-01-27       Impact factor: 5.578

3.  An intermediate-risk multiple myeloma subgroup is defined by sIL-6r: levels synergistically increase with incidence of SNP rs2228145 and 1q21 amplification.

Authors:  Owen W Stephens; Qing Zhang; Pingping Qu; Yiming Zhou; Shweta Chavan; Erming Tian; David R Williams; Joshua Epstein; Bart Barlogie; John D Shaughnessy
Journal:  Blood       Date:  2011-11-09       Impact factor: 22.113

4.  Severe intellectual disability and autistic features associated with microduplication 2q23.1.

Authors:  Brian H Y Chung; Sureni Mullegama; Christian R Marshall; Anath C Lionel; Rosanna Weksberg; Lucie Dupuis; Lauren Brick; Chumei Li; Stephen W Scherer; Swaroop Aradhya; D James Stavropoulos; Sarah H Elsea; Roberto Mendoza-Londono
Journal:  Eur J Hum Genet       Date:  2011-11-16       Impact factor: 4.246

5.  Proximal microdeletions and microduplications of 1q21.1 contribute to variable abnormal phenotypes.

Authors:  Jill A Rosenfeld; Ryan N Traylor; G Bradley Schaefer; Elizabeth W McPherson; Blake C Ballif; Eva Klopocki; Stefan Mundlos; Lisa G Shaffer; Arthur S Aylsworth
Journal:  Eur J Hum Genet       Date:  2012-02-08       Impact factor: 4.246

Review 6.  CNVs: harbingers of a rare variant revolution in psychiatric genetics.

Authors:  Dheeraj Malhotra; Jonathan Sebat
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

Review 7.  Genetic architectures of psychiatric disorders: the emerging picture and its implications.

Authors:  Patrick F Sullivan; Mark J Daly; Michael O'Donovan
Journal:  Nat Rev Genet       Date:  2012-07-10       Impact factor: 53.242

Review 8.  Copy number variations in schizophrenia: critical review and new perspectives on concepts of genetics and disease.

Authors:  Anne S Bassett; Stephen W Scherer; Linda M Brzustowicz
Journal:  Am J Psychiatry       Date:  2010-05-03       Impact factor: 18.112

Review 9.  Genome-wide approaches to schizophrenia.

Authors:  Jubao Duan; Alan R Sanders; Pablo V Gejman
Journal:  Brain Res Bull       Date:  2010-04-28       Impact factor: 4.077

10.  New mutations and intellectual function.

Authors:  James R Lupski
Journal:  Nat Genet       Date:  2010-12       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.